000 | 01231 a2200313 4500 | ||
---|---|---|---|
005 | 20250516225350.0 | ||
264 | 0 | _c20150416 | |
008 | 201504s 0 0 eng d | ||
022 | _a1540-336X | ||
024 | 7 |
_a10.1097/PPO.0000000000000063 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGettinger, Scott | |
245 | 0 | 0 |
_aB7-H1/PD-1 blockade therapy in non-small cell lung cancer: current status and future direction. _h[electronic resource] |
260 |
_bCancer journal (Sudbury, Mass.) _c |
||
300 |
_a281-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 |
_aB7-H1 Antigen _xantagonists & inhibitors |
650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunotherapy _xmethods |
650 | 0 | 4 |
_aLung Neoplasms _xdiet therapy |
650 | 0 | 4 |
_aProgrammed Cell Death 1 Receptor _xantagonists & inhibitors |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
700 | 1 | _aHerbst, Roy S | |
773 | 0 |
_tCancer journal (Sudbury, Mass.) _gvol. 20 _gno. 4 _gp. 281-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/PPO.0000000000000063 _zAvailable from publisher's website |
999 |
_c24075127 _d24075127 |